We conclude that laparoscopic resection of a primary, symptomatic Stage IV colorectal tumor is indicated in patients without bowel obstruction or after bowel decompression and when the rectal tumor has not invaded adjacent organs. Laparoscopic surgery appears to be safer than open surgery in such cases, and chemotherapy can be initiated earlier. The resulting prolonged survival reinforces the validity of this treatment.
Introduction
Advances in medical treatment have extended the life expectancy of patients with stage IV colorectal cancer, and resection of the primary tumor is now considered beneficial in many cases. Whether such resection should be performed is determined on a case-by-case basis, under the JSCCR Colorectal Cancer Treatment Guidelines 2016. 1) Evaluation includes symptoms attributed to the primary tumor, then status of the distant metastases, the patient's general condition, estimated life expectancy, surgical risk, and the predicted efficacy of resection in terms of symptom alleviation. The treatment objectives in cases of unresectable stage IV colorectal cancer are to prolong the patients' life and improve or at least maintain the pa-tient's quality of life.
In the past, if the primary tumor was deemed resectable, regardless of the presence of one or more unresectable distant metastatic foci, the primary tumor was resected as extensively as possible, and chemotherapy was then performed. However, advances in chemotherapy have improved control of the primary tumor . As a result, the number of cases in which the primary tumor is not resected before chemotherapy is increasing, and resection is often delayed until the primary tumor becomes symptomatic. 2) Cirocchi et al. 3) reported no difference in survival outcomes between surgical and non-surgical treatment of an asymptomatic primary tumor in cases of Stage IV colorectal cancer. Later, Kurushima et al. 4) reported that new chemotherapy methods reduced the clinical significance of resection of the primary tumor when such resection was performed as first-line treatment for patients with an asymptomatic primary tumor and unresectable distant focal metastases. This has led them to administer chemotherapy in advance of surgery.
We believe that chemotherapy should be performed prior to surgery in cases of Stage IV colorectal cancer for which the primary lesion is symptomatic but for which the disease is otherwise asymptomatic. This depends, of course, on whether the patient, according to his or her general condition, is deemed suitable for surgery.
We are especially interested in laparoscopic intervention and have performed a number of laparoscopic resections of the primary tumor. Reports of similar laparoscopic interventions are few, and there is some concern over which method, laparoscopy or laparotomy, is better. For this reason, we conducted a retrospective study of the safety and validity of laparoscopic resection of the primary tumor performed in patients with Stage IV colorectal cancer who suffered symptoms due to the primary lesion.
Patients and Methods
At our institution, the indications for resection of a symptomatic primary lesion in cases of stage IV colorectal cancer are as follows: (1) the patient is anemic (hemoglobin [Hb] <9 mg/L, with the anemia believed to be the result of tumor hemorrhage), or intestinal stenosis is present (fiberscope cannot be inserted into the bowel proximal to the tumor or decompression has been necessary); (2) the patient's American Society of Anesthesiologists (ASA) physical status is class ≤III; and (3) the patient's expected survival with treatment is ≥3 months. The indications for laparoscopic surgery in particular are as follows: (1) preoperative imaging has shown no obvious invasion of other organs; (2) decompression (with a rectal decompression tube, for example, has been effective for intestinal obstruction; and (3) the patient has provided informed consent for the laparoscopic surgery.
The comparative study described herein included 59 patients with a symptomatic primary colorectal cancer lesion. The primary tumor was treated by open surgery (n=18, OP group) or by laparoscopic surgery (n=41, LA group). No patient who had required a temporary colostomy due to intestinal obstruction was included. The surgeries were performed between July 2008 and December 2015, with the open surgeries performed by board-certified surgeons in gastroenterology and the laparoscopic surgeries performed by surgeons accredited under the Endoscopic Surgical Skill Qualification System or certified by the Japan Society for Endoscopic Surgery.
To determine the safety and validity of the laparoscopic surgery, patients' medical records were reviewed, and the following variables were compared between the two groups of patients: patient and tumor characteristics, patients' intraoperative and postoperative clinical courses, and survival outcomes. Postoperative complications were assessed according to the Clavien-Dindo classification system, and those ranked grade ≥2 were noted.
Data are shown as mean (±SD) or median values or the number (percentage) of patients. Betweengroup differences in continuous variables were analyzed by the Student t-test whereas between-group differences in categorical variables were analyzed by chi-squared test. Survival was plotted by the KaplanMeier method and analyzed by log-rank test. A value of P <0.05 was considered significant for all analyses.
This study was approved by the St. Marianna University School of Medicine bioethics committee (approval no.: 3648).
Results

Patient characteristics
As shown in Table 1 , the age of the patients was 65.1 (±11.1) years, and age of those in the OP group was 66 (±12.0) years. The male:female ratio was 28:13 in the LA group and 9:9 in the OP group. The ASA physical statuses did not differ significantly between the two groups, but 2 patients (4.8%) in the LA group and 1 patient (5.5%) in the OP group were of Anemia due to tumor hemorrhage (Hb <9.0 mg/L) was noted in 36 patients (88%) in the LA group and in 15 patients (83%) in the OP group, with no significant difference between them (P=0.68). There was also no between-group difference in the side on which the tumor occurred (left or right). Location of the tumor in the rectum was significantly more prevalent in the LA group (19 patients [46%]) than in the OP group (1 patient [5.5%]) (P=0.001). There were no significant between-group differences in the prevalence of either a cT3 tumors (25 patients [61%] in the LA group and 11 patients [61%] in the OP group) or a cT4a tumors (16 patients [39%] in the LA group and 3 patients [16%] in the OP group). However, the difference in the prevalence of a cT4b tumor was significant (0 patients in the LA group vs. 
Surgical factors
Surgical factors are shown in Table 2 . Operation time was 218.5 (±69.4) minutes in the LA group and 142.5 (±60.5) minutes in the OP group (P<0.001). The blood loss volume was 106.6 (±199.5) mL in the LA group and 422.5 (±720.9) mL in the OP group (P=0.0056). Surgeries performed were as follows: colectomy in 22 patients (54%) in the LA group and 17 patients (94%) in the OP group (P = 0.002) and rectal resection in 19 patients (46%) in the LA group and in 1 patient (6%) in the OP group (P = 0.002). Due to extensive (or massive) local invasion of the primary tumor, resection of the uterus and ovaries along with the primary tumor was necessary in 2 patients (11%) in the OP group, and resection of the small intestine along with the primary tumor was necessary in 2 patients (11%) in this group. Although simultaneous resection was more common in the OP group, the between-group difference was not significant.
Although simultaneous resection was more common in the OP group, the between-group difference was not significant.
The extent of dissection was D1 in 2 patients (5%) in the LA group and 3 patients (17%) in the OP group, D2 in 12 patients (29%) and 8 patients (44%), respectively, and D3 in 27 patients (66%) and 7 patients (39%), respectively. The rate of D3 dissection was relatively but not significantly high in the LA group. Conversion to laparotomy was necessary in 1 patient (2.4%) in the LA group due to high-grade adhesions resulting from a previous abdominal surgery.
Postoperative complications
Postoperatively, surgical site infection (SSI), pancreatitis, urinary retention, and gastric ulcer occurred in 1 patient each (2.4%) in the LA group, but SSI occurred in 5 patients (5.5%) in the OP group and was thus significantly more common in this group (P=0.008) ( Table 3 ). The SSI was not deep in any patient in either group. All complications resolved with conservative treatment.
Postoperative clinical course
The 
Overall survival time
Median survival was significantly longer in the LA group (36 months) than that in the OP group (20 months) (P=0.0167) (Fig. 1) .
Discussion
Laparoscopic palliative surgery for Stage IV colorectal cancer, regardless of whether the primary tumor is symptomatic, was first reported by Milsom et al. 5) in 2000. In a series of patients who underwent elective resection for Stage IV colorectal cancer, Law et al. 6) reported significantly fewer complications after laparoscopic surgery than after open surgery; the rate of conversion from laparoscopic to open surgery was 13%, and median survival times were statistically equivalent at 16.0 months and 16.4 months, respectively. In addition, Hida et al. 7) reported fewer complications after laparoscopic surgery than after open surgery, a conversion rate of 12.4%, and no statistical difference in the time to the start of postoperative chemotherapy (28 days vs. 33 days, respectively). Median survival time was significantly longer after laparoscopic surgery (25.9 months) than that after open surgery (22.3 months) (P=0.04).
Reports comparing laparoscopic surgery and open surgery for symptomatic primary tumors in cases of Stage IV colorectal cancer are few. In a series of patients reported by Allaix et al. 8) , complications and outcomes were equivalent, the hospital stay after laparoscopic surgery was shorter, and there was no significant difference in median survival time. In addition, Akagi et al. 9) reported a significantly longer operation time of 220.5 minutes with laparoscopic surgery in comparison to 173 minutes with open surgery (P=0.015) but a significantly lower blood loss volume of 150 mL after laparoscopic surgery vs. 190 mL after open surgery. Complications occurred in significantly fewer of their patients who underwent laparoscopic surgery than in those who underwent open surgery (13.3% vs. 26.7%) (P=0.0042), respectively. The rate of conversion to laparotomy was 11.2%. The time to the start of postoperative chemotherapy was significantly shorter after laparoscopic surgery than after open surgery (27 days vs. 32 days), but median survival time did not differ significantly, at 22.0 months vs. 22.2 months, respectively.
According to Akagi et al. 9) , tumor-related symptoms are recognized on the basis of anemia (Hb <9 mg/L) attributed to tumor hemorrhage and intestinal stenosis, as described above. Anemia was present in 22% of their patients who underwent laparoscopic surgery and in 20% of those who underwent open surgery, whereas stenosis was present preoperatively in 91% and 91%, respectively, and both of these disorders were observed preoperatively in 14% and 11%, respectively.. Under the same criteria, anemia was present preoperatively in 36 patients (88%) in our LA group and in 15 patients (83%) in our OP group, and 5 patients (12%) in our LA group and 8 patients (44%) in our OP group required decompression for preoperative intestinal obstruction. Anemia and preoperative intestinal obstruction were not present together in any patient in the LA group but were present together in 5 patients (28%) in the OP group. Like Akagi et al. 9) , we showed the operation time to be significantly longer but the blood loss volume to be significantly lower in our LA group than in our OP group. The relatively high SSI rate in our OP group and the low rate at which conversion to laparotomy was necessary in our LA group indicated that laparoscopic palliative resection of the primary lesion can be performed safely in patients with Stage IV colorectal cancer.
Operation time was longer in our LA group than in our OP group, but there was little blood loss. Further, with the exception of SSI, for which the incidence was significantly low in our LA group, complications did not differ between our two groups. Therefore, it can be said that laparoscopic resection We believe that regardless of the patients' symptoms attributable to the primary lesion, prolongation of the patient's life after resection of the primary lesion is due mainly to advances in chemotherapy. 10) Use of molecular-targeted drugs in addition to multidrug therapy with oxaliplatin or irinotecan and 5-FU/ leucovorin has become standard treatment for unresectable, advanced colorectal cancer. 1) According to Poultsides et al., 10) asymptomatic primary tumors became resectable after chemotherapy in 20.2% of their patients with Stage IV colorectal cancer, and chemotherapy has become the first-choice treatment in cases of Stage IV colorectal cancer with an asymptomatic primary lesion. There have been reports of favorable outcomes when resection of a symptomatic primary lesion and chemotherapy have been performed, 12, 13) although some studies have indicated that delaying the start of chemotherapy has little effect on prognosis. 14) Akagi et al., 9) reported initiation of chemotherapy in 79.6% of patients after laparoscopic surgery and 78.9% after open surgery. The chemotherapy regimens were not identical, but the differences were not significant, and although the period before the start of postoperative chemotherapy was shorter after laparoscopic surgery, no significant difference was observed in terms of survival time. Chemotherapy was not performed preoperatively in our patients. It was performed postoperatively in 36 patients (87%) in our LA group and in 11 patients (72%) in our OP group. There were also 5 patients in each group for whom chemotherapy could not be performed because of their reduced cognitive function. Surgery had no effect in any of these 10 patients, and the decision that individual patients not undergo chemotherapy, either by their own choice or because of cognitive decline, was not challenged.
With regard to the chemotherapy regimen, molecular targeted drugs were added to oxaliplatin or irinotecan and 5-FU/leucovorin in patients for whom they were indicated, although the regimens were not identical. For this reason, we did not include the chemotherapy regimens in our analysis. However, the mean time to the start of postoperative chemotherapy was significantly shorter in the LA group (24.5 days) than in the OP group (35.6 days), and the overall survival time was significantly longer in the LA group (36 months) than in the OP group (20 months). Thus, the transition to chemotherapy after laparoscopic surgery was smooth. We do not believe that the approximate 10-day difference in the time to chemotherapy explains the major difference in overall survival. Rather, we believe that the difference was due to low levels of cytokines related to tumor proliferation in the LA group, but this remains a question for future research.
In choosing between open surgical resection or laparoscopic resection of the primary tumor, ileus is a factor that should be evaluated. When ileus is present, a laparoscopic approach can result in an insufficient operative field, with spillage of the contents of the dilated bowel or bowel injury more likely than when open surgery is performed. However, Law et al. 15) compared laparoscopic surgery against open surgery performed for obstructive colorectal cancer, both of which were carried out shortly after endoscopic stent-ing of the large intestine, and they consider laparoscopic surgery a feasible option when the obstruction is adequately addressed. On the basis of our study, we believe laparoscopic resection to be acceptable, even in cases of cT4b cancer, as long as decompression is adequate. There have been reports of safe laparoscopic resection of the primary tumor in cases of abdominal wall invasion, but open resection remains the best option if the tumor has spread as far as the greater omentum. 16) Therefore, laparoscopic resection of a symptomatic primary tumor, even a rectal tumor, in cases of Stage IV colorectal cancer is appropriate when ileus is corrected and tumor invasion is limited to adjacent organs.
Conclusion
LA for Symptomatic Stage IV colorectal cancer can be safely performed if there is no obstruction before surgery, cases where it is sufficiently decompressed, and cases without extensive infiltration in other organs are selected safely, which can be an option for surgical therapy. Furthermore, there is not much difference in LA has less bleeding volume, SSI, and other complications, it can be said that it is a safe surgical procedure like OP.
